Management of dental patients taking common hemostasis-altering medications

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 103, Issue SUPPL., 2007, Pages S45.e1-S45.e11

  Aframian, Doron J ^a   Lalla, Rajesh V ^b   Peterson, Douglas E ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947273152     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.11.011     Document Type: Article

References (53)

1. Akopov S.E., Suzuki S., Fredieu A., Kidwell C.S., Saver J.L., and Cohen S.N. Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines?. Cerebrovasc Dis 19 5 (2005) 337-342 Epub April 8, 2005
2. Alexander R., Ferretti A.C., and Sorensen J.R. Stop the nonsense not the anticoagulants: a matter of life and death. N Y State Dent J 68 9 (2002) 24-26
3. Beirne O.R. Evidence to continue oral anticoagulant therapy for ambulatory oral surgery. J Oral Maxillofac Surg 63 4 (2005) 540-545
4. Carter G., Goss A.N., Lloyd J., and Tocchetti R. Current concepts of the management of dental extractions for patients taking warfarin. Aust Dent J 48 2 (2003) 89-96 quiz 138
5. Chugani V. Management of dental patients on warfarin therapy in a primary care setting. Dent Update 31 7 (2004) 379-382 384
6. Dunn A.S., and Turpie A.G. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163 8 (2003) 901-908
7. Jeske A.H., and Suchko G.D. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 134 11 (2003) 1492-1497
8. Little J.W., Miller C.S., Henry R.G., and McIntosh B.A. Antithrombotic agents: implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 5 (2002) 544-551
9. Lockhart P.B., Gibson J., Pond S.H., and Leitch J. Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs. Br Dent J 195 9 (2003) 495-501
10. Patton L.L., and Ship J.A. Treatment of patients with bleeding disorders. Dent Clin North Am 38 3 (1994) 465-482
11. Rice P.J., Perry R.J., Afzal Z., and Stockley I.H. Antibacterial prescribing and warfarin: a review. Br Dent J 194 8 (2003) 411-415
12. Scully C., and Wolff A. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 1 (2002) 57-64
13. Schardt-Sacco D. Update on coagulopathies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 5 (2000) 559-563
14. Wahl M.J. Dental surgery in anticoagulated patients. Arch Intern Med 158 15 (1998) 1610-1616
15. Wahl M.J. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 131 1 (2000) 77-81
16. Hirsh J., Dalen J., Anderson D.R., Poller L., Bussey H., Ansell J., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119 1 Suppl (2001) 8S-21S
17. Owens C.D., and Belkin M. Thrombosis and coagulation: operative management of the anticoagulated patient. Surg Clin North Am 85 6 (2005) 1179-1189 x
18. Hirsh J., Fuster V., Ansell J., Halperin J.L., and American Heart Association/American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41 9 (2003) 1633-1652
19. Salem D.N., Stein P.D., Al-Ahmad A., Bussey H.I., Horstkotte D., Miller N., et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 457-482
20. Büller H.R., Agnelli G., Hull R.D., Hyers T.M., Prins M.H., and Raskob G.E. Antithrombotic yherapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 401-428
21. Hirsh J., Dalen J.E., Deykin D., and Poller L. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 102 4 Suppl (1992) 312S-326S
22. Steinberg M.J., and Moores III J.F. Use of INR to assess degree of anticoagulation in patients who have dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 2 (1995) 175-177
23. Herman W.W., Konzelman Jr. J.L., and Sutley S.H. Current perspectives on dental patients receiving coumarin anticoagulant therapy. J Am Dent Assoc 128 3 (1997) 327-335
24. White R.H., McKittrick T., Hutchinson R., and Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 122 1 (1995) 40-42
25. Genewein U., Haeberli A., Straub P.W., and Beer J.H. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 92 2 (1996) 479-485
26. Sindet-Pedersen S., Ramstrom G., Bernvil S., and Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 320 13 (1989) 840-843
27. Carter G., and Goss A. Tranexamic acid mouthwash-a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 32 5 (2003) 504-507
28. Blinder D., Manor Y., Martinowitz U., Taicher S., and Hashomer T. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 2 (1999) 137-140
29. Al-Belasy F.A., and Amer M.Z. Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery. J Oral Maxillofac Surg 61 12 (2003) 1405-1409
30. Carter G., Goss A., Lloyd J., and Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg 61 12 (2003) 1432-1435
31. Evans I.L., Sayers M.S., Gibbons A.J., Price G., Snooks H., and Sugar A.W. Can warfarin be continued during dental extraction?. Results of a randomized controlled trial. Br J Oral Maxillofac Surg 40 3 (2002) 248-252
32. Gaspar R., Brenner B., Ardekian L., Peled M., and Laufer D. Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication. Quintessence Int 28 6 (1997) 375-379
33. Halfpenny W., Fraser J.S., and Adlam D.M. Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 3 (2001) 257-259
34. Bodner L., Weinstein J.M., and Baumgarten A.K. Efficacy of fibrin sealant in patients on various levels of oral anticoagulant undergoing oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 4 (1998) 421-424
35. Zanon E., Martinelli F., Bacci C., Cordioli G., and Girolami A. Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 14 1 (2003) 27-30
36. Souto J.C., Oliver A., Zuazu-Jausoro I., Vives A., and Fontcuberta J. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 54 1 (1996) 27-32 discussion 323
37. Ramstrom G., Sindet-Pedersen S., Hall G., Blomback M., and Alander U. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 51 11 (1993) 1211-1216
38. Brennan M.T., Shariff G., Kent M.L., Fox P.C., and Lockhart P.B. Relationship between bleeding time test and postextraction bleeding in a healthy control population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 4 (2002) 439-443
39. Brennan MT, Fox PC, Lockhart PB. Role of an INR device in a hospital dental practice. Paper presented at: 60th Annual Meeting of the American Academy of Oral Medicine; May 4, 2006; San Juan, Puerto Rico.
40. Davydov L., Yermolnik M., and Cuni L.J. Warfarin and amoxicillin/clavulanate drug interaction. Ann Pharmacother 37 3 (2003) 367-370
41. Pemberton M.N., Oliver R.J., and Theaker E.D. Miconazole oral gel and drug interactions. Br Dent J 196 9 (2004) 529-531
42. Ansell J., Hirsh J., Dalen J., Bussey H., Anderson D., Poller L., et al. Managing oral anticoagulant therapy. Chest 119 1 Suppl (2001) 22S-38S
43. Choay J., Petitou M., Lormeau J.C., Sinay P., Casu B., and Gatti G. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun 116 2 (1983) 492-499
44. Hirsh J., Warkentin T.E., Shaughnessy S.G., Anand S.S., Halperin J.L., Raschke R., et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119 1 Suppl (2001) 64S-94S
45. Hewitt R.L., Chun K.L., and Flint L.M. Current clinical concepts in perioperative anticoagulation. Am Surg 65 3 (1999) 270-273
46. Hennekens C.H., Dyken M.L., and Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 96 8 (1997) 2751-2753
47. Dalen J.E. Aspirin to prevent heart attack and stroke: what's the right dose?. Am J Med 119 3 (2006) 198-202
48. Ardekian L., Gaspar R., Peled M., Brener B., and Laufer D. Does low-dose aspirin therapy complicate oral surgical procedures?. J Am Dent Assoc 131 3 (2000) 331-335
49. Madan G.A., Madan S.G., Madan G., and Madan A.D. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg 63 9 (2005) 1262-1265
50. Valerin M. Relationship between aspirin use and postoperative bleeding from dental extractions in a healthy population. Paper presented at: 60th Annual Meeting of the American Academy of Oral Medicine; May 4, 2006; San Juan, Puerto Rico.
51. Schrodi J., Recio L., Fiorellini J., Howell H., Goodson M., and Karimbux N. The effect of aspirin on the periodontal parameter bleeding on probing. J Periodontol 73 8 (2002) 871-876
52. Jamieson D.G., Parekh A., and Ezekowitz M.D. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. J Cardiovasc Pharmacol Ther 10 3 (2005) 153-161
53. Hanson J., de Leval X., David J.L., Supuran C., Pirotte B., and Dogne J.M. Progress in the field of GPIIb/IIIa antagonists. Curr Med Chem Cardiovasc Hematol Agents 2 2 (2004) 157-167